Telesis Bio
Stock Forecast, Prediction & Price Target

Telesis Bio Financial Estimates

Telesis Bio Revenue Estimates

Telesis Bio EBITDA Estimates

Telesis Bio Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025
Revenue
 
% change YoY
$11.04M
 
N/A
$27.43M
 
148.43%
$27.50M
 
0.26%
Avg: $37M
Low: $37M
High: $37M
avg. 34.50%
Net Income
 
% change YoY
$-38.95M
 
N/A
$-48.47M
 
-24.41%
$-47.72M
 
1.54%
Avg: $-319.99M
Low: $-319.99M
High: $-319.99M
avg. -570.50%
EBITDA
 
% change YoY
$-33.86M
 
N/A
$-46.51M
 
-37.35%
$-40.49M
 
12.93%
Avg: $-37M
Low: $-37M
High: $-37M
avg. 8.62%
EPS
 
% change YoY
-$1.33
 
N/A
-$1.65
 
-24.06%
-$1.64
 
0.60%
Avg: -$10.72
Low: -$10.72
High: -$10.72
avg. -553.65%
Operating Expenses
 
% change YoY
$39.67M
 
N/A
$62.08M
 
56.47%
$63.48M
 
2.26%
Avg: $50.32M
Low: $50.32M
High: $50.32M
avg. -20.72%

FAQ

What is Telesis Bio stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -570.50% in 2025-2025.

We have gathered data from 1 analysts. Their low estimate is -319.99M, average is -319.99M and high is -319.99M.

What is Telesis Bio stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 34.50% in 2025-2025.

We have gathered data from 1 analysts. Their low revenue estimate is $37M, average is $37M and high is $37M.

What is Telesis Bio stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -553.65% in 2025-2025.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$10.72, average is -$10.72 and high is $-10.72.